Europe Radiotherapy Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

12/feb/2018 03:06:51 pbi Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Radiotherapy is a painless treatment which is extensively used in cancer treatment. It works on a principle of damaging cancerous cells by destruction of DNA inside cells by radiation.  It slows down the cancerous cells growth and provides comfort by relieving the patients with cancer symptoms. Cancer is the abnormal growth and spread of cells which arises from a change in single cell. Change may be due to external agents and inherited genetic factors and can affect almost any body part. Cancer can be prevented by avoiding exposure to the common risk factors, by surgery, radiotherapy and chemotherapy.

 Radiotherapy market in Europe is driven by various factors like growing number of cancer patients, favourable non-government and government funds in R&D of cancer treatment. Furthermore, inclination towards non-invasive techniques and decreased cost of treatment in the developed areas are expected to boost the growth of the radiotherapy market in Europe. However, side effects like skin problems, fertility issues, loss of hair and appetite and also harms caused to other healthy cells because of high dosage of radiation will restrain the growth of radiotherapy market in Europe. Moreover, costs associated with training the professionals, difficulty in maintenance and up gradation of equipment are expected to hamper the Europe radiotherapy market.


A sample of this report is available upon request @ 



The Europe radiotherapy market is classified on the basis of type, application, equipment, end user, and geography.


Based on equipment, the Europe radiotherapy market is segmented into the following


·         Radiation therapy stimulators

·         Treatment planning systems

·         Linear Accelerators



Based on type, the Europe radiotherapy market is segmented into the following


·         External therapy

·         Intensity modulated therapy

·         External beam therapy

·         Image guided radiation therapy

·         Stereotactic body radiation therapy

·         Intra operative radiation therapy

·         Electron therapy

·         Proton Therapy

·         Tomtherapy

·         Internal therapy

·         Brachytherapy

·         Radioisotope or radio nuclide therapy

·         Radio – embolization


Based on application, the Europe radiotherapy market is segmented into the following


·         Skin and lip cancer

·         Head and neck cancer

·         Breast cancer

·         Prostate cancer

·         Cervical cancer

·         Lung cancer

·         Spine cancer



Based on end user, the Europe radiotherapy market is segmented into the following


·         Hospitals

·         Oncology centers

·         R&D centers

·         Diagnostic centers


To view TOC of this report is available upon request @



Europe has wide variances in accessing radiation therapy services, scantiness in infrastructure and skilled professionals. As per, International Atomic Energy Agency (IAEA) report 2012, about 1286 radiotherapy centres registered in DIRAC database in Europe. Where Germany has largest number with 289 centres, France with 177, Italy with 172 centres and Spain has 117 centres respectively. Netherlands and UK along with Nordic countries (Scandinavia, Finland and Iceland) have the most centralized radiotherapy infrastructure with more treatment equipment and fewer facilities at each centre.


Need more information about this report @




European market is expanding with both new and old technologies. Most prevalent cancers in European region are breast cancer, prostate cancer, colorectal and lung cancer. Europe radiotherapy market is segmented into major countries like UK, Germany, France, Spain, Switzerland, Netherlands, Italy, Russia and rest of the Europe. In recent year, there has been a rapid development in the radiotherapy field in Europe region owing to growing threat of multiple cancers and mortality rate which has pulled the government and healthcare manufacturers in increasing funds for research labs to develop treatments and preventive techniques to treat cancer.



Some of the players in Europe radiotherapy market are Ion Beam Applications SA (Belgium), RaySearch Laboratories AB (Sweden), Elekta AB (Sweden), Nordion Inc. (Canada), C. R. Bard Inc. (U.S.), Varian Medical Systems Inc. (U.S.), Mevion Medical Systems Inc. (U.S.), IsoRay Medical Inc. (U.S.), Mitsubishi Electric Corporation (Japan) and Accuray Incorporated (U.S.).


Get access to full summary @


blog comments powered by Disqus è un servizio offerto da Factotum Srl